SEC 13F Intelligence

Telemetry Investments, L.L.C. / AIMT

Telemetry Investments, L.L.C.’s Aimmune Therapeutics Inc Position

Does Telemetry Investments, L.L.C. own Aimmune Therapeutics Inc (AIMT)? Not currently — the last reported position was 15.5K shares worth $534,000 in Q3 2020; the fund’s latest 13F (Q4 2022) no longer reports it.

Position Value
$534,000
Q3 2020
Shares
15.5K
% of Portfolio
+1.16%
Quarters Held
1
position exited

Position History AIMT

Reported value by quarter
Q3 ’20: $534,000Q3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202015.5K$534,000+1.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Telemetry Investments, L.L.C.’s full portfolio or all institutional holders of AIMT.